What is the toxic dose of clonazepam (Klonopin) for the human body?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Toxic Dose of Clonazepam

The toxic dose of clonazepam varies by individual, but doses exceeding 2.0 mg significantly increase risk of toxicity with symptoms including severe sedation, ataxia, confusion, and respiratory depression, while doses above 6.0 mg are considered potentially dangerous in most adults without tolerance. 1

Understanding Clonazepam Toxicity

Clonazepam is a potent benzodiazepine with the following characteristics:

  • 20 times more potent than diazepam on a milligram-per-milligram basis 1
  • Long half-life of 30-40 hours 1
  • High bioavailability (90%) 1
  • Rapid absorption with maximum plasma concentrations reached within 1-4 hours 1

Therapeutic vs. Toxic Doses

  • Therapeutic dose range: 0.5-2.0 mg for situational panic attacks 1
  • Minimum effective dose: 1.0 mg/day for anxiety disorders 1
  • Potentially toxic doses: >2.0 mg increases risk of significant adverse effects 1
  • Higher risk doses: 3.0-6.0 mg may be used in specific clinical scenarios but carry increased toxicity risk 2, 3

Signs and Symptoms of Toxicity

Clonazepam toxicity manifests in a dose-dependent manner:

Moderate Toxicity

  • Excessive sedation and somnolence
  • Ataxia (loss of coordination)
  • Cognitive impairment
  • Memory dysfunction
  • Dizziness 1

Severe Toxicity

  • Confusion
  • Respiratory depression (especially when combined with other CNS depressants)
  • Hypotension
  • Loss of consciousness
  • Paradoxical agitation 4

Risk Factors for Toxicity

Several factors can lower the threshold for clonazepam toxicity:

  1. Concurrent use of other CNS depressants:

    • Opioids
    • Alcohol
    • Other benzodiazepines
    • Antipsychotics 4
  2. Patient-specific factors:

    • Advanced age
    • Hepatic impairment
    • Respiratory conditions (especially sleep apnea)
    • Neurodegenerative disorders 1

Management of Clonazepam Toxicity

Antidote Administration

  • Flumazenil: Can be effective for pure benzodiazepine toxicity at 0.2 mg, titrated up to 1 mg (adult dose) 4
  • Caution: Flumazenil may precipitate seizures in patients with benzodiazepine dependence or when other pro-convulsant drugs are present 4

Important Considerations

  • If combined opioid and benzodiazepine poisoning is suspected, administer naloxone first 4
  • Flumazenil may not fully reverse respiratory depression, particularly in mixed overdoses 4
  • Monitor for withdrawal symptoms which can be life-threatening 1

Prevention of Toxicity

  • Start with low doses (0.5 mg) and increase gradually 5
  • Regular monitoring for side effects, especially during dose adjustments
  • Avoid combining with other sedatives when possible 4
  • Limit initial prescriptions to 2-4 weeks when possible 1
  • Regularly reassess the need for continued therapy 1

Special Populations

  • Elderly: Require dose reduction due to increased sensitivity and decreased clearance 1
  • Hepatic impairment: May require dose adjustments due to altered metabolism 1
  • Patients with sleep apnea: Even therapeutic doses (0.5-1.0 mg) can worsen this condition 1

Clonazepam toxicity should be taken seriously as benzodiazepine overdose can be life-threatening, particularly when combined with other CNS depressants or in vulnerable populations.

References

Guideline

Clonazepam for Situational Panic Attacks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clonazepam in the treatment of prolonged depression.

Journal of affective disorders, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clonazepam. A review of a new anticonvulsant drug.

Archives of neurology, 1976

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.